267 related items for PubMed ID: 23306862
1. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis.
Ayodele OE, Okpechi IG, Swanepoel CR.
Int Urol Nephrol; 2013 Oct; 45(5):1289-300. PubMed ID: 23306862
[Abstract] [Full Text] [Related]
2. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
Ayodele OE, Okpechi IG, Swanepoel CR.
Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
[Abstract] [Full Text] [Related]
3. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
[Abstract] [Full Text] [Related]
4. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.
Al Arfaj AS, Khalil N, Al Saleh S.
Rheumatol Int; 2009 Jul; 29(9):1057-67. PubMed ID: 19381639
[Abstract] [Full Text] [Related]
5. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[Abstract] [Full Text] [Related]
6. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
Almalki AH, Alrowaie FA, Alhozali HM, Almalki NK, Alsubei AI, Alturki MS, Sadagah LF.
Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
[Abstract] [Full Text] [Related]
7. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[Abstract] [Full Text] [Related]
8. Lupus nephritis in children: prognostic significance of clinicopathological findings.
Emre S, Bilge I, Sirin A, Kilicaslan I, Nayir A, Oktem F, Uysal V.
Nephron; 2001 Feb; 87(2):118-26. PubMed ID: 11244305
[Abstract] [Full Text] [Related]
9. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
[Abstract] [Full Text] [Related]
10. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS, Kim S, Chin HJ.
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[Abstract] [Full Text] [Related]
11. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[Abstract] [Full Text] [Related]
12. A retrospective analysis of clinical presentation of lupus nephritis.
Singh S, Zhou XJ, Ahn C, Saxena R.
Am J Med Sci; 2011 Dec; 342(6):467-73. PubMed ID: 21681076
[Abstract] [Full Text] [Related]
13. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K, Yu Y, Tang Z, Liu Z, Li L.
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[Abstract] [Full Text] [Related]
14. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[Abstract] [Full Text] [Related]
15. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[Abstract] [Full Text] [Related]
16. Outcome of patients with membranous lupus nephritis in Cape Town South Africa.
Okpechi IG, Ayodele OE, Jones ES, Duffield M, Swanepoel CR.
Nephrol Dial Transplant; 2012 Sep; 27(9):3509-15. PubMed ID: 22610989
[Abstract] [Full Text] [Related]
17. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
[Abstract] [Full Text] [Related]
18. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM, Hung WT, Liao YW, Hsu CY, Hsieh TY, Chen HH, Hsieh CW, Lin CT, Lai KL, Tang KT, Tseng CW, Huang WN, Chen YH.
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[Abstract] [Full Text] [Related]
19. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[Abstract] [Full Text] [Related]
20. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Contreras G, Tozman E, Nahar N, Metz D.
Lupus; 2005 Aug; 14 Suppl 1():s33-8. PubMed ID: 15803929
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
